Axsome Therapeutics to Present at the 15th Annual Needham Healthcare Conference
Apr 04, 2016 11:00 am UTC| Business
NEW YORK, April 04, 2016 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...
Natus Medical Announces Preliminary Revenue for the First Quarter 2016
Apr 04, 2016 11:00 am UTC| Business
PLEASANTON, Calif., April 04, 2016 -- Natus Medical Incorporated (NASDAQ:BABY) today announced preliminary revenue for is first quarter ended March 31, 2016. Revenue for the first quarter of 2016 is expected to be...
Apr 04, 2016 11:00 am UTC| Business
Obtained FDA clearance in November 2015 for Ablatherm Robotic HIFU;Fourth quarter 2015 HIFU Division revenues tripled over fourth quarter 2014;Overall fourth quarter 2015 revenues increased 82% over 2014 to EUR 11.8...
Plug Power to Exhibit and Host Press Conference at MODEX 2016
Apr 04, 2016 11:00 am UTC| Business
LATHAM, N.Y., April 04, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, today announced it will exhibit and host a press conference at MODEX 2016, happening now through...
Apr 04, 2016 11:00 am UTC| Business
Positive data from Zilretta Phase 2b and Phase 3 clinical trials demonstrate consistent efficacy across both studies with substantial and persistent pain reliefIn the Phase 3 trial Zilretta, in contrast to...
Mitek’s Michael Hagen To Speak at Money20/20 Europe
Apr 04, 2016 11:00 am UTC| Business
SAN DIEGO and HAARLEM, Netherlands, April 04, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, announced that managing director of...
Curis Announces Publication of CUDC-907 Phase 1 Clinical Trial Data in Lancet Oncology
Apr 04, 2016 11:00 am UTC| Business
-- Latest analysis of data presented at the American Society of Hematology’s annual meeting in December, 2015 ---- CUDC-907 demonstrated objective responses, including complete responses, in patients with...